Who are the peers of the Novartis India?

Jun 06 2025 04:12 PM IST
share
Share Via
Novartis India's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, and others. In terms of management risk, growth, and capital structure, Novartis India shows average performance, with a 1-year return of -3.58%, the lowest among its peers.
Peers: The peers of Novartis India are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Indoco Remedies, Senores Pharma., SMS Pharma., and Amrutanjan Healt.

Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and Amrutanjan Healt, while Good management risk is found at Divi's Lab., Torrent Pharma, and SMS Pharma. Average management risk is present at Novartis India, Indoco Remedies, and Syncom Formul., and Below Average management risk is noted at Senores Pharma. Growth is Excellent for Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and Senores Pharma., while Good growth is seen at Novartis India. Below Average growth is found at Divi's Lab., Torrent Pharma, Indoco Remedies, SMS Pharma., and Amrutanjan Healt, and the rest have Below Average growth. Capital Structure is Excellent for Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, and Amrutanjan Healt, while Good is noted at Torrent Pharma, Average at Indoco Remedies and SMS Pharma., and Below Average at Senores Pharma.

Return Snapshot: The peer with the highest 1-year return is Divi's Lab. at 51.69%, while the lowest is Novartis India at -3.58%. Novartis India's 1-year return is lower than that of all its peers. Additionally, Indoco Remedies and SMS Pharma. have negative six-month returns.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Novartis India falling/rising?
Dec 05 2025 12:56 AM IST
share
Share Via
Why is Novartis India falling/rising?
Nov 06 2025 10:05 PM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 05 2025 08:06 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 03 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 02 2025 08:04 AM IST
share
Share Via